Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human induced pluripotent stem cells (hiPSC), enveloped in elastin-like recombinamers for cell therapy of type 1 diabetes mellitus (T1D): preliminary data

25 Apr 2023

Abstract excerpt

Introduction: Therapeutic application and study of type 1 diabetes disease could benefit from the use of functional β islet-like cells derived from human induced pluripotent stem cells (hiPSCs). Considerable efforts have been made to develop increasingly effective hiPSC differentiation protocols, although critical issues related to cost, the percentage of differentiated cells that are obtained, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes and associated disorders
Share to Pancreatic function and diabetes
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37180045
DOI: 10.3389/fbioe.2023.1046206

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human induced pluripotent stem cells (hiPSC), enveloped in elastin-like recombinamers for cell therapy of type 1 diabetes mellitus (T1D): preliminary dataPMID 37180045Read ↗

Pluripotent stem cell replacement approaches to treat type 1 diabetes.Semantic proximity Read ↗

Inside the Matrix: A pancreas-derived hydrogel for the culture of hiPSC-derived pancreatic endocrine cellsSemantic proximity Read ↗

Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells.Semantic proximity Read ↗

In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cellsSemantic proximity Read ↗

Manufacturing clinical‐grade human induced pluripotent stem cell‐derived beta cells for diabetes treatmentSemantic proximity Read ↗

The functional performance of microencapsulated human pancreatic islet-derived precursor cells.Semantic proximity Read ↗

Encapsulation boosts islet-cell signature in differentiating human induced pluripotent stem cells via integrin signallingSemantic proximity Read ↗

Encapsulation boosts islet-cell signature in differentiating human induced pluripotent stem cells via integrin signalling.Semantic proximity Read ↗

Recent Advances in the Development of Bioartificial Pancreas Using 3D Bioprinting for the Treatment of Type 1 Diabetes: A ReviewSemantic proximity Read ↗

Bioprinting of Human Primary and iPSC-derived Islets with Retained and Comparable FunctionalitySemantic proximity Read ↗

Designed peptide-grafted hydrogels for human pluripotent stem cell culture and differentiationSemantic proximity Read ↗

Encapsulated, genetically engineered cells, secreting glucagon-like peptide-1 for the treatment of non-insulin-dependent diabetes mellitus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.